|
Nov 8
|
3 No-Brainer Stocks to Buy With $500 Right Now
|
|
Nov 7
|
Mirati's (MRTX) Q3 Loss Narrows, Sales Miss Expectations
|
|
Nov 6
|
Bristol Myers Squibb to Present Data from Innovative Cardiovascular Portfolio at the American Heart Association Scientific Sessions 2023
|
|
Nov 6
|
Bristol Myers pays $100M for a different kind of ADC
|
|
Nov 2
|
Prothena Corp PLC (PRTA) Reports Q3 2023 Financial Results
|
|
Nov 2
|
Bristol Myers Squibb’s First Disclosures and New Data at ASH 2023 Highlight Company’s Leadership and Progress in Cell Therapy, Targeted Protein Degradation and Novel Approaches in Hematology
|
|
Nov 2
|
Bristol Myers Squibb to Participate in the 2023 UBS BioPharma Conference
|
|
Oct 31
|
Bristol Myers Squibb Appoints Christopher Boerner, Ph.D., to Chair of the Board of Directors, Effective April 1, 2024
|
|
Oct 31
|
Bristol-Myers Squibb Insiders Sell US$25m Of Stock, Possibly Signalling Caution
|
|
Sep 20
|
Rockville life sciences firm Emmes names former J&J exec Peter Ronco as its new CEO
|
|
Sep 20
|
13 Best Beaten Down Stocks To Buy Now
|
|
Sep 20
|
Bristol Myers Squibb Announces Dividend
|
|
Sep 19
|
UPDATE 3-BeiGene to go solo with cancer drug after Novartis deal termination
|
|
Sep 18
|
FDA approves GSK's unique myelofibrosis treatment Ojjaara
|
|
Sep 17
|
Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance
|
|
Sep 14
|
The 3 Most Undervalued Pharma Stocks to Buy in September 2023
|
|
Sep 14
|
Biotech Stock Roundup: MRNAs Pipeline News, RCKT, BCYC Rally on Study Updates
|
|
Sep 14
|
Bristol Myers plans to double experimental treatments to expand research pipeline
|
|
Sep 14
|
Bristol Myers Squibb Highlights Advancing Pipeline and Differentiated Research Platforms to Support Long-Term Sustainable Growth at R&D Day
|
|
Sep 12
|
Bristol Myers, J&J invest in Boston biotech's $72M VC round
|